The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention.

Doctors have said there is a risk that weight loss jabs such as Ozempic and Mounjaro could raise the risk of being diagnosed ...

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

The announcement follows new research that suggested drugs like Wegovy, Mounjaro and Ozempic slashed the ... for patients who are at high risk of obesity-related cancer, and possibly even other ...

Recent studies suggest that popular weight loss drugs like Ozempic may offer surprising ... evidence linking weight loss to a decreased risk of cancer, this study suggests that the injections ...

Mounjaro, Ozempic and other fat-melting injections ... no medications have been proven to lower the cancer risk associated with obesity. 'Our study begins to fill that gap by evaluating GLP ...

Ozempic and Rybelsus have been approved ... “They also improve insulin sensitivity, which can lower the risk of insulin-resistant conditions linked to cancer.” Obesity is a chronic health ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's (NOVOb.CO), opens new tab Ozempic may modestly reduce the risk of obesity-related cancers, especially colorectal cancer ...